|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 298.80 SEK | -0.40% |
|
-3.24% | -3.86% |
| 20/02 | Nordea Raises Price Target for Bioarctic to 240 Kronor (236), Reiterates Sell | FW |
| 19/02 | Lannebo Health and New Technology Down 5.1 Percent in January — Bico and Raysearch Weigh on Performance | FW |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 2.33Cr | -68.81% | -88.79% | -18.24% | -15.41% | 2.12x | ||
| 725.46Cr | 9.67% | 17.9% | 6.77% | 3.48% | 1.5x | ||
| 534.3Cr | 5.37% | 8.37% | 11.07% | 4.42% | -3.99x | ||
| 240.81Cr | 11.88% | 13.83% | 2.46% | 2.14% | 1.28x | ||
| 1.63TCr | 8.34% | 13.38% | 32.9% | 4.79% | 3.63x | ||
| 85Cr | -31.67% | -18.92% | - | - | 1.57x | ||
| 253.02Cr | 17.83% | 20.93% | 70.23% | 22.13% | -0.89x | ||
| 856.64Cr | 6.51% | 14.79% | 11.46% | 4.17% | 2.2x | ||
| 94Cr | -40.36% | -40.47% | -69.35% | -9.5% | 3.01x | ||
| 127.18Cr | -19.27% | -3.71% | -38.64% | -6.61% | -65.61x | ||
| 197.82Cr | 4.23% | 28.66% | 13.31% | 8.32% | 0.34x | ||
| 401.54Cr | -3.59% | 19.77% | 15.46% | 6.99% | 1.98x | ||
| 1.29Cr | -1,409.6% | -1,383.2% | -148.95% | - | 0.4x | ||
| 121.96Cr | 6.02% | 31.45% | 15.37% | 11.65% | 0.43x | ||
| 51Cr | -13.19% | -41.67% | -31.26% | -21.6% | -0.14x | ||
| 828.17Cr | 9.56% | 19.29% | 12.39% | 6.87% | 1.66x | ||
| 3.92Cr | -794.04% | -891.07% | -28.49% | -18.41% | 3.05x | ||
| Average | 362.08Cr | -135.36% | -134.09% | -8.97% | 0.23% | -2.79x | |
| Weighted average by Cap. | 523.97Cr | -65.03% | -60.66% | 1.26% | 2.6% | -1.47x |
- Stock Market
- Equities
- BIOA B Stock
- Sector BioArctic AB
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















